EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 84 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,695,000 | -38.4% | 449,338 | -57.6% | 0.60% | -56.0% |
| Q3 2019 | $10,865,000 | -9.8% | 1,060,043 | -6.7% | 1.37% | +12.7% |
| Q2 2019 | $12,042,000 | -46.0% | 1,136,043 | -28.8% | 1.22% | -40.8% |
| Q1 2019 | $22,307,000 | +37.6% | 1,595,643 | 0.0% | 2.06% | +26.8% |
| Q4 2018 | $16,212,000 | +30.0% | 1,595,643 | +53.5% | 1.62% | +44.3% |
| Q3 2018 | $12,474,000 | -1.6% | 1,039,500 | 0.0% | 1.12% | -6.9% |
| Q2 2018 | $12,682,000 | +4413.2% | 1,039,500 | +7225.6% | 1.21% | +987.4% |
| Q2 2016 | $281,000 | -91.2% | 14,190 | -92.5% | 0.11% | -90.0% |
| Q1 2016 | $3,179,000 | – | 189,545 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
| 683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
| RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
| UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
| XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
| DRW Securities, LLC | 120,365 | $37 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |